Friday Review, News Alert, New Options Ideas

Furious Friday Gainers:

Friday turned out to be an excellent cap to a solid trading week for us, with the markets ripping, and everything we were looking at making nice intraday upswings. We highlighted four potential plays in our premarket report for the day and really liked the activity that was registered. We’ve been navigating this relatively dry period for earnings reporters with success over the past couple of weeks.

Friday’s winning ideas were the PLAY 08/16 $42-43 Calls, the C Weekly $66-68 Calls, the SPY 07/12 $556-557 Calls, and the NVDA Weekly $127-128 Calls. Here were the runs they recorded on the day:

PLAY 08/16 $42-43 Calls
$42:
 .85-1.76 (+106%)
$43: .65-1.35 (+108%)
_____

C Weekly $66-68 Calls
$66: .02-.14 (+600%)
$67: .01-.04 (+300%)
$68: .01-.05 (+400%)
_____

SPY 07/12 $556-557 Calls
$556: 1.74-7.67 (+341%)
$557: 1.17-6.63 (+467%)
_____

NVDA Weekly $127-128 Calls
$127: 1.47-4.95 (+237%)
$128: .96-3.90 (+306%)


Fresh Options Ideas:
SPY 07/15 $561-562 Calls
DJT Weekly $44-46 Calls
NVDA Weekly $130-131 Calls
TSLA Weekly $250-255 Calls


Cannabis Bioscience International Holdings, Inc. (OTCMKTS:CBIH) – News Update:

More news has hit from CBIH this morning that we wanted to pass along to those of you who have been following its story with us. One of the things we like best about the way this company operates, are the frequent PR updates that it provides.

HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) — Cannabis Bioscience International Holdings (OTCMKTS:CBIH) has initiated a strategic move to expand its presence in the cannabis market by filing applications for crucial licenses covering the manufacturing, production, and retail components of its cannabis product range.

Preparations are underway for the production and distribution of our products, and continue to foster revenue expansion, which could only be achieved through the practical application of the skills and experiences gained over the past 15 years. Therefore, we are now navigating the licensing phase for our manufacturing units. This involves securing permissions for the production, manufacture and provision of cannabinoid-based items. (>>View Full PR)

For more information on CBIH, please visit cbih.net
and/or contact Peter Nicosia at (585) 703-6565 with any inquiries.


Extended Watchlist: 
DATS, MIRA, AREB, CPOP, SCNI, PHUN, ARTL